Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

11.10
Delayed Data
As of 9:37am ET
 0.00 / 0.00%
Today’s Change
8.55
Today|||52-Week Range
11.43
+2.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$579.3M

Company Description

SciClone Pharmaceuticals, Inc. is a pharmaceutical company. It engages in the development of therapeutics treatment for oncology, infectious diseases and cardiovascular disorders. Its product includes ZADAXIN, Holoxan, Mesna, Endoxan, Farlutal, Methotrexate. Estracyt, DC Bead, Angiomax, Neucardin, Cleviprex, Loramyc, and VIBATIV. The company was founded in 1990 and is headquartered in Foster City, CA.

Contact Information

SciClone Pharmaceuticals, Inc.
950 Tower Lane
Foster City California 94404-2125
P:(650) 358-3456
Investor Relations:

Employees

Shareholders

Other institutional43.84%
Mutual fund holders34.41%
Individual stakeholders15.48%

Top Executives

Friedhelm BlobelPresident, Chief Executive Officer & Director
Wai-Shun CheungChief Financial Officer & Senior VP-Finance
Carey ChernSecretary & Chief Compliance Officer
Lan XieCFO-China Operations & Vice President-Finance
Hong ZhaoChief Executive Officer-China Operations